Company: LNAI
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001731122-25-001316
Chunk: 721

Company: Lunai Bioworks Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 6
Chunk 721
---
 year ended June 30, 2025 is as follows:

    Schedule of information regarding segment reporting 

    RENB 
    BioSymetrics 
    RENC 
    Total
  
    General and administrative 
    $14,904,855  
    $211,401  
    $2,763,794  
    $17,880,050 
  
    Research and development 
     502,896  
     26,029  
     8,503  
     537,428 
  
    Goodwill impairment 
     —  
     —  
     170,419,429  
     170,419,429 
  
    Depreciation and amortization 
     122,305  
     450  
     6,340  
     129,095 

    Segment operating loss 
    $15,530,056  
    $237,880  
    $173,198,066  
     188,966,002 

Geographic information:

RENB,
BioSymetrics and RENC are managed on a worldwide basis but operate in offices located in the United States and the Netherlands, respectively.
The geographic information analyses the Company’s operations and assets based on the country in which each segment operates. In
presenting this geographic information, segment operating results have been based on the geographic location in which the services were
provided to the segment and segment assets were based on the geographic location of the assets.

    F-35

NOTE 15 — SUBSEQUENT EVENTS

On
September 18, 2025, the Company filed a Certificate of Amendment to the Certificate of Incorporation of the Company (the “Certificate
of Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-10
reverse stock split of the shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”),
either issued and outstanding or held by the Company as treasury stock, effective as of 12:01 a.m. (New York time) on September 29, 2025
(the “Reverse Stock Split”). The Common Stock will begin trading on a
reverse stock split-adjusted basis on The Nasdaq Capital Market on September 30, 2025.

On September 18, 2025, the Company entered into the
First Amendment to Convertible Promissory Note whereby the January 2024 Note